Health Industry News

Australians with asthma urged to exercise vigilance this winter

The National Asthma Council Australia has issued a warning to Australians living with asthma, urging them to protect their health and to be prepared as the cold and flu season kicks in. According to the Council, around 40,000 Australians are hospitalised and 400 die from asthma each year, with winter being a particularly difficult season…

Read More

A potential vaccine for cancer: new data

After nearly half a century of trying to identify a vaccine that might wipe out cancers, similarly to the way vaccine targets influenza or pneumococcal pneumonia, scientists might have made a breakthrough in this arena. According to an article published in The Australian (July 7, 2017), scientists from a German biotechnology company, Biontech, as well as…

Read More

Apotex launches Oviit a new range of vitamins and minerals

Apotex announced the launch of its new premium value, Pharmacy Only range of vitamin and mineral supplements (VMS), Oviit today (July 3, 2017). Expansion into this high growth VMS category signals further diversification of Apotex’s over-the-counter (OTC) portfolio, and a strategy for the generic drug manufacturer to restore value to the VMS category for pharmacy.…

Read More

Aussie biotech appoints American royalty to its Board of Directors

VIVA! Communications are thrilled to be working with Australian medical technology company Medibio as they today (June 4, 2017) announce the appointment of mental health advocate and former U.S. congressman, Patrick J.  Kennedy, to their Board of Directors. Patrick J. Kennedy is a former member of the U.S. House of Representatives and America’s leading political…

Read More

Government adds $142 million in medicines to PBS

As of July 1, 2017, the Federal Government has made AUD$142 million in new medicine listings to the Pharmaceutical Benefits Scheme (PBS), in a bid to make more medicines affordable to all Australians. Among the new listings, the PBS will fund access to vorinostat to treat patients living a subtype of blood cancer, non-Hodgkin’s lymphoma called…

Read More